Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Tempest Therapeutics, Inc. logo

Tempest Therapeutics, Inc. (TPST) Stock Ticker

NASDAQ: TPST · Healthcare · Biotechnology
$0.829-2.47%
USD · as of 2026-09-27 · market cap $13.2M
Open TPST in TickrDownload for iPhone

TPST right now

Options price it to move more than 9 in 10 stocks.
Options expect by Oct 6±15.3%
Options expect by Oct 29±31.7%
Priced in for Nov 4 earnings±34.8%
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full TPST picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on TPST
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Tempest Therapeutics, Inc.

Tempest Therapeutics Inc. is an oncology company, currently in the clinical development phase, dedicated to advancing novel small molecule drugs designed to combat cancer. The firm's pipeline highlights two key therapeutic candidates: TPST-1495, a compound functioning as a dual inhibitor of EP2 and EP4 receptors (which are implicated in prostaglandin E2 signaling), currently undergoing initial human trials for solid tumor indications. The second candidate, TPST-1120, is a targeted blocker of peroxisome proliferator-activated receptor alpha, also progressing through Phase 1 studies for solid tumors. Beyond these clinical assets, Tempest is exploring TREX-1, a pivotal cellular enzyme known for its role in regulating the innate immune response within cancerous growths. Established in 2011, Tempest Therapeutics Inc. is headquartered in South San Francisco, California, having previously operated as a subsidiary of Inception Sciences, Inc.

TPST stock facts

Ticker symbolTPST
ExchangeNASDAQ Capital Market
SectorHealthcare
IndustryBiotechnology
Market cap$13.2M
CEOMatthew Angel
Employees4
HeadquartersBrisbane, CA, US
IPO date2012-11-12
Websitewww.tempesttx.com

What you can see for TPST on Tickr

Live TPST price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the TPST report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Tempest Therapeutics, Inc.?

The ticker symbol for Tempest Therapeutics, Inc. is TPST, listed on the NASDAQ Capital Market.

What is TPST?

Tempest Therapeutics Inc. is an oncology company, currently in the clinical development phase, dedicated to advancing novel small molecule drugs designed to combat cancer. The firm's pipeline highlights two key therapeutic candidates: TPST-1495, a compound functioning as a dual inhibitor of EP2 and EP4 receptors (which are implicated in prostaglandin E2 signaling), currently undergoing initial…

HomeExploreMarketLists
All pages